Indo Us Biotech — 360° view

Indo Us Biotech, a company in the Other Agricultural Products industry, reported revenue of ₹15 crore and a net loss of ₹3.67 crore for the September 2026 quarter.

Indo Us Biotech (NSE: INDOUS) closed at ₹65.46 on 20 Nov 2026, down 47.5% over the past year. Its market capitalisation is ₹131 crore and it trades at 30.2 times earnings.

Share price
₹65.46 (20 Nov 2026)
Market cap
₹131 Cr (20 Nov 2026)
P/E
30.24 (20 Nov 2026)
Revenue
₹15 Cr (September 2026 quarter)
Net profit
₹-4 Cr (September 2026 quarter)
ROCE
14.5% (FY26)
ROE
15.3% (FY26)
Book value
₹45.8 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹159.00 / ₹57.50 (20 Nov 2026)
1-year return
-47.5% (to 20 Nov 2026)
Sector
Fast Moving Consumer Goods
Industry
Other Agricultural Products
Symbol
NSE: INDOUS

Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.